The Sjogren's syndrome pipeline presents significant opportunities with 10+ companies and 12+ drugs, focusing on novel therapeutic approaches. Key products in development include monoclonal antibodies ...

Dublin, July 31, 2025 (GLOBE NEWSWIRE) -- The "Sicca Syndrome (Sjogren) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering. The clinical trial ...

What is Sjögren’s Syndrome? With a typical age of onset between 40 and 60 years old, Sjögren’s (pronounced show-grins) syndrome is a progressive autoimmune disease affecting the areas of the body ...

A deep-learning artificial intelligence model trained on salivary gland biopsy images shows potential for classifying focus scores and Sjögren disease.

PHILADELPHIA -- Remibrutinib, an investigational Bruton's tyrosine kinase (BTK) inhibitor, appeared effective in reducing signs of Sjogren's syndrome in a randomized, placebo-controlled trial. Scores ...

Ainos (AIMD) has received Institutional Review Board approval from Shuang Ho Hospital, affiliated with Taipei Medical University, for its clinical trial of VELDONA in treating Sjogren’s syndrome.

Past efforts to determine the true prevalence of Sjögren disease have been challenging, especially among underserved and Indigenous populations.

Williams tells GMA how the autoimmune disease forced her out of the U.S. Open. Sept. 1, 2011— -- The autoimmune disease that forced tennis star Venus Williams out of the U.S. Open caused ...

Please provide your email address to receive an email when new articles are posted on . In rheumatology, there is no shortage of conditions that are difficult to diagnose, with diseases like ...